-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Aquestive Therapeutics, Raises Price Target to $8

Benzinga·11/07/2025 12:54:04
Listen to the news
Piper Sandler analyst David Amsellem maintains Aquestive Therapeutics (NASDAQ:AQST) with a Overweight and raises the price target from $5 to $8.